Burçak Karaca

1.4k total citations
102 papers, 998 citations indexed

About

Burçak Karaca is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Burçak Karaca has authored 102 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 28 papers in Molecular Biology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Burçak Karaca's work include Cancer Immunotherapy and Biomarkers (15 papers), Colorectal Cancer Treatments and Studies (9 papers) and Research in Cotton Cultivation (8 papers). Burçak Karaca is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Colorectal Cancer Treatments and Studies (9 papers) and Research in Cotton Cultivation (8 papers). Burçak Karaca collaborates with scholars based in Türkiye, Switzerland and United States. Burçak Karaca's co-authors include Rüçhan Uslu, Harika Atmaca, Bülent Karabulut, Aslı Kısım, Selim Uzunoğlu, Emir Bozkurt, Çiğdem Erten, Canfeza Sezgin, Ulus Ali Şanlı and Sibel Eyigör and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Burçak Karaca

89 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burçak Karaca Türkiye 19 374 301 188 129 116 102 998
Celalettin Camcı Türkiye 18 297 0.8× 228 0.8× 168 0.9× 165 1.3× 106 0.9× 65 983
Chong Yang China 18 316 0.8× 355 1.2× 156 0.8× 240 1.9× 157 1.4× 60 1.1k
Fikret Arpacı Türkiye 19 456 1.2× 267 0.9× 154 0.8× 113 0.9× 88 0.8× 74 1.1k
Mansoor Ahmed United Kingdom 17 248 0.7× 372 1.2× 147 0.8× 70 0.5× 91 0.8× 52 1.1k
Wings T.Y. Loo Hong Kong 20 290 0.8× 410 1.4× 90 0.5× 82 0.6× 240 2.1× 63 1.1k
Li Liang China 20 389 1.0× 554 1.8× 191 1.0× 93 0.7× 178 1.5× 67 1.3k
Shu‐Hui Lin Taiwan 22 363 1.0× 548 1.8× 105 0.6× 155 1.2× 238 2.1× 87 1.3k
Xuan Zhao China 15 302 0.8× 598 2.0× 123 0.7× 67 0.5× 84 0.7× 54 1.1k
Kiyoshi Komuta Japan 19 849 2.3× 209 0.7× 494 2.6× 119 0.9× 136 1.2× 76 1.4k
Jeng‐Fong Chiou Taiwan 16 248 0.7× 246 0.8× 154 0.8× 93 0.7× 106 0.9× 56 797

Countries citing papers authored by Burçak Karaca

Since Specialization
Citations

This map shows the geographic impact of Burçak Karaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burçak Karaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burçak Karaca more than expected).

Fields of papers citing papers by Burçak Karaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burçak Karaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burçak Karaca. The network helps show where Burçak Karaca may publish in the future.

Co-authorship network of co-authors of Burçak Karaca

This figure shows the co-authorship network connecting the top 25 collaborators of Burçak Karaca. A scholar is included among the top collaborators of Burçak Karaca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burçak Karaca. Burçak Karaca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karaca, Burçak, et al.. (2025). Dynamic blood-based biomarkers predict early response to ipilimumab and nivolumab in advanced melanoma. Clinical & Translational Oncology. 28(2). 635–644.
2.
3.
Karaca, Burçak, et al.. (2025). Prognostic utility of the CALLY index in metastatic melanoma: building a nomogram for Patients on Anti-PD-1 therapy. Clinical & Translational Oncology. 27(9). 3770–3780. 4 indexed citations
4.
Karaca, Burçak, et al.. (2025). Dual‐Functioning Metal‐Organic Frameworks: Methotrexate‐Loaded Gadolinium MOFs as Drug Carriers and Radiosensitizers. Chemistry - A European Journal. 31(24). e202404106–e202404106. 3 indexed citations
5.
Karaca, Burçak, et al.. (2025). Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics. Frontiers in Immunology. 16. 1616325–1616325. 2 indexed citations
6.
Karaca, Burçak, et al.. (2024). Guillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib. Balkan Medical Journal. 41(4). 312–313.
7.
8.
9.
Atmaca, Harika, et al.. (2019). Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells. Future Oncology. 16(3). 4485–4495. 9 indexed citations
10.
Yürekli, Banu Şarer, Burçak Karaca, Aslı Kısım, et al.. (2017). AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells. Journal of Endocrinological Investigation. 41(2). 233–240. 6 indexed citations
11.
Çakar, Burcu, Atike Pınar Erdoğan, Raika Durusoy, et al.. (2015). The Role of Body Mass Index in Triple Negative Breast Cancer. Oncology Research and Treatment. 38(10). 518–522. 12 indexed citations
12.
Karaca, Burçak, et al.. (2012). Somatostatin treatment of a persistent chyloperitoneum following abdominal aortic surgery. Journal of Vascular Surgery. 56(5). 1409–1412. 6 indexed citations
13.
Bozkurt, Emir, Harika Atmaca, Aslı Kısım, et al.. (2012). Effects ofThymus serpyllumExtract on Cell Proliferation, Apoptosis and Epigenetic Events in Human Breast Cancer Cells. Nutrition and Cancer. 64(8). 1245–1250. 41 indexed citations
14.
Uzunoğlu, Selim, Burçak Karaca, Harika Atmaca, et al.. (2011). Targeting Bcl-2 Protein to Enhance Chemosensitivity of Hormone Refractory Prostate Cancer Cell Line, DU-145 by a Synergistic Combination of Docetaxel and Gossypol. Turkiye Klinikleri Journal of Medical Sciences. 31(4). 859–866. 1 indexed citations
15.
Sarsık, Banu, Ender Hür, Muhittin Ertilav, et al.. (2011). A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis. Journal of Nephrology. 24(3). 359–365. 8 indexed citations
16.
Karaca, Burçak, et al.. (2011). Leptomeningeal carcinomatosis of gastric adenocarcinoma. The Turkish Journal of Gastroenterology. 22(2). 195–198. 18 indexed citations
17.
Eyigör, Can, et al.. (2010). Does the tumor localization in advanced pancreatic cancer have an influence on the management of symptoms and pain?. PubMed. 15(3). 543–6. 7 indexed citations
18.
Küçükzeybek, Yüksel, Burçak Karaca, Bülent Karabulut, et al.. (2009). Trastuzumab Induced Maculopapular Skin Reactions Localized on the Left Forearm and Arm: A Case Report. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(6). 1743–1746. 2 indexed citations
19.
Atmaca, Harika, Burçak Karaca, Selim Uzunoğlu, et al.. (2009). Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells. European Cytokine Network. 20(3). 121–130. 22 indexed citations
20.
Yürekli, Banu Şarer, Burçak Karaca, Şevki Çetinkalp, & Rüçhan Uslu. (2009). Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs. Medical Hypotheses. 73(4). 606–607. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celalettin Camcı Breakdown of academic impact, for papers by Chong Yang Breakdown of academic impact, for papers by Fikret Arpacı Breakdown of academic impact, for papers by Mansoor Ahmed Breakdown of academic impact, for papers by Wings T.Y. Loo Breakdown of academic impact, for papers by Li Liang Breakdown of academic impact, for papers by Shu‐Hui Lin Breakdown of academic impact, for papers by Xuan Zhao Breakdown of academic impact, for papers by Kiyoshi Komuta Breakdown of academic impact, for papers by Jeng‐Fong Chiou
Rankless by CCL
2026